CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

RemedyRePack Inc. recalls Clindamycin HCl Capsule

Read the official FDA notice

Published
14 May 2025
Units affected
23 bottles/30 count- 690 capsules
Agency
FDA
Country
United States

The hazard

CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02

Brand / company
RemedyRePack Inc.
Codes / lots
Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.
Distribution
Within U.S - PA, VA, FL.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 14 May 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.